A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study

Overview of attention for article published in Investigational New Drugs, November 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 35 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 360 followers.

#GBM_papers: A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study https://t.co/KMxajkVvL5

02 Dec 2019

Reply Repost Favourite

A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study. https://t.co/UYhHHc2UZk

11 Nov 2019

Reply Repost Favourite